- World rank, all time
- #36,807 of 42,892
- Rank in United States
- #7,772 of 8,685
- Research works
- 207 ▲ 81% vs 2013–17
- Citations
- 1.6k 7.7 per fractional work
- Top-10% rate
- 13.2% record average 16.5%
- Open access
- 43% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.0×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 6.0×
- Immunology and Microbiology 4.8×
- Pharmacology, Toxicology and Pharmaceutics 1.8×
- Medicine 1.8×
- Neuroscience 1.5×
- Economics, Econometrics and Finance 0.8×
- Computer Science 0.6×
- Arts and Humanities 0.6×
- Social Sciences 0.6×
- Chemical Engineering 0.5×
- Decision Sciences 0.5×
- Health Professions 0.5×
- Business, Management and Accounting 0.4×
- Environmental Science 0.4×
- Engineering 0.3×
- Psychology 0.2×
- Agricultural and Biological Sciences 0.2×
- Mathematics 0.1×
Who are the top researchers at Personalis (United States)?
Ranked on the composite score, Jason Harris and Richard Chen lead among researchers whose main affiliation is Personalis (United States).
- 1 Jason Harris United States · #513,034 worldwide 52 citations · 18 works
- 2 Richard Chen United States · #598,963 worldwide 92 citations · 36 works
Which keywords describe research at Personalis (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Targeted Therapy, Cancer Genomics, Mutational Signatures, Tumor Microenvironment, Gene Expression, Immune Checkpoint Blockade, PD-1 and PD-L1 and Antigen Presentation.
- Education
- Cancer
- Inflammation
- Immunity
- Cancer Immunotherapy
- Fc Receptors
- Single-Cell
- Machine Learning
- Epitope Prediction
- Monoclonal Antibodies
- Molecular Characterization
- Hereditary Syndromes
- Adjuvant Chemotherapy
- PD-1 and PD-L1
- Antigen Presentation
- Tumor Microenvironment
- Cancer Genomics
- Targeted Therapy
- Mutational Signatures
- Gene Expression
- Immune Checkpoint Blockade
- Cancer Risk
- Genetic Testing
- Microsatellite Instability
- RNA-Seq
- Glycosylation
- Immunotherapy
- Peptide-MHC Binding
- Transcriptomics
- Therapeutic Antibodies
- Artificial Intelligence
- Innate Immunity
- Oxidative Stress
- Chemotherapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 34 words, with their numbers
- Targeted Therapy6▲ 56×2 topics
- Cancer Genomics5▲ 155×1 topic
- Mutational Signatures5▲ 155×1 topic
- Tumor Microenvironment4▲ 20×5 topics
- Gene Expression3▲ 10×6 topics
- Antigen Presentation3▲ 66×2 topics
- Immune Checkpoint Blockade3▲ 54×1 topic
- PD-1 and PD-L13▲ 54×1 topic
- Cancer Risk2▲ 24×4 topics
- Adjuvant Chemotherapy2▲ 72×2 topics
- Genetic Testing2▲ 44×2 topics
- Hereditary Syndromes2▲ 158×1 topic
- Microsatellite Instability2▲ 158×1 topic
- Molecular Characterization2▲ 28×2 topics
- RNA-Seq2▲ 40×2 topics
- Monoclonal Antibodies2▲ 47×2 topics
- Glycosylation2▲ 34×3 topics
- Epitope Prediction2▲ 136×1 topic
- Immunotherapy2▲ 5.0×9 topics
- Machine Learning2◆ 1.08×7 topics
- Peptide-MHC Binding2▲ 136×1 topic
- Single-Cell2▲ 82×1 topic
- Transcriptomics2▲ 82×1 topic
- Fc Receptors2▲ 60×1 topic
- Therapeutic Antibodies2▲ 47×1 topic
- Cancer Immunotherapy1▲ 20×3 topics
- Artificial Intelligence1▲ 2.1×6 topics
- Immunity1▲ 7.4×2 topics
- Innate Immunity1▲ 9.3×3 topics
- Inflammation1▲ 1.33×11 topics
- Oxidative Stress1▲ 1.69×10 topics
- Cancer1▲ 1.77×7 topics
- Chemotherapy1▲ 3.4×6 topics
- Education1▲ 1.35×4 topics
Which research topics does Personalis (United States) publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Genetic factors in colorectal cancer and Single-cell and spatial transcriptomics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 5 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 3 Genetic factors in colorectal cancer Pathology and Forensic Medicine 2 works
- 4 Single-cell and spatial transcriptomics Molecular Biology 2 works
- 5 vaccines and immunoinformatics approaches Molecular Biology 2 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 7 Immunotherapy and Immune Responses Immunology 1 works
- 8 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 1 works
- 9 Molecular Biology Techniques and Applications Molecular Biology 1 works
- 10 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Personalis (United States)'s research output changed?
Output in 2018–2022 was 81% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Menlo Park
- SRI International
- SLAC National Accelerator Laboratory
- Stanford Synchrotron Radiation Lightsource
- Exponent (United States)
- Kavli Institute for Particle Astrophysics and Cosmology
- Meta (United States)
- Pacific Biosciences (United States)
- Linac Coherent Light Source
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.